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List of abbreviations 
AB   Antibiotics 
ANC   Absolute neutrophil count 
CFU   Colony forming unit  
CoNS   Coagulase-negative staphylococci 
CRP   C-reactive protein  
CSF   Cerebrospinal fluid 
FWS   Fever without source 
Hpf   High power field 
IBI   Invasive bacterial infection 
IL-6   Interleukin-6 
LP   Lumbar puncture 
PCT   Procalcitonin 
PED   Pediatric emergency department 
SBI   Serious bacterial infection 
UA   Urinalysis 
URTI   Upper respiratory tract infection  
WBC   White blood cell count 
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Abstract 
Title: Fever in infants below 2 months of age: clinical management and outcome 
Degree Project in Medicine, Programme in Medicine, Sahlgrenska Academy at the University 
of Gothenburg, Sweden 2019. 
Author: Michelle Bäckman Smith, medical student.   
Introduction: Fever in the young infant is a common reason for guardians bringing their 
newborn child to the emergency room. Neonates have a particularly high risk of developing 
serious bacterial infections (SBI) but classical signs or symptoms are often lacking. This has 
led to some controversy regarding management, testing and optimal treatment, i.e choosing 
between treating all or using clinical and laboratory parameters to decide on antibiotic 
treatment. 
Aim: To describe management and physician compliance to existing guidelines of febrile 
young infants aged 60 days attending the pediatric emergency department (PED).  
Method: Retrospective observational study based on medical records from patients 60 days 
of age with fever being their main reason for visiting the PED at The Queen Silvia Children´s 
Hospital in Gothenburg between 1st of January 2015 and 31st of December 2017. 
Results: Of 625 infants included in the study 299 (47.8%) were hospitalized. 184 (29.4%) 
received antibiotics at initial approach, 44.6% in the 0-30 days of age group. 152 (24.3%) had 
a blood culture done and 86 (13.8%) infants had a lumbar puncture taken, 28.4% in the 0-30-
day age group. In total, 10.6% (66/625) of all patients had an SBI. Majority (79%) had a 
pyelonephritis without an invasive bacterial infection. Leukocyturia was present in 54/65 (83%) 
of patients with an SBI in comparison with 71/457 (16%) that did not have an SBI (p=0.001). 
Two infants died. 
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Conclusion: Outcome for febrile infants at the PED in Gothenburg is favorable although more 
restricted management. A low frequency of lumbar punctures, antibiotic treatment and 
admission rate amongst the youngest infants and in the overall group was observed.  
 
 
 
 
 
 
 
 
 
 
 
 6 
Background 
Introduction 
Fever is one of the most common causes for guardians to bring their child to the pediatric 
emergency department (PED) (1). This is even more important when it comes to newborn 
children because of their higher risk of serious bacterial infections (SBI) or invasive bacterial 
infections (IBI). Parents are therefore advised to bring febrile infants (temperature 38°C) to 
the PED by the child health care centers (2) because fever can be a sign of a serious bacterial 
infection (SBI) such as meningitis, bacteremia or urinary tract infection. Alternate definitions 
for SBI also include pneumonia, bone and joint infections, skin and soft tissue as well as 
bacterial enteritis in the term SBI (3, 4). IBI is defined as an isolated bacterial pathogen found 
in blood or in Cerebrospinal fluid (CSF) (5). 
The clinical assessment of a newborn child can be difficult because of the differences in 
presentation. Infants with meningitis can present with minimal symptoms and appear well while 
others present with more typical symptoms like altered status, seizures or bulging fontanelle. 
Hence, it is difficult for medical personnel to manage these infants which has led to a rather 
low threshold to do extensive testing e.g. lumbar puncture (LP) and cultures from urine, blood 
and CSF, give empiric antibiotics (AB) and admit the infant to the ward (3). To assist decide 
which infant is at low risk for SBI and does not need this extensive evaluation there are several 
different criteria or guidelines to follow and they all vary with regard to laboratory evaluation 
and recommendation for administration of antibiotics. E.g. Rochester criteria (6) does not 
recommend LP or empiric antibiotics for low-risk patients while the NICE-guidelines (7) 
regards all infants under 3 moths and with a temperature of 38C at high risk and recommends 
LP in all cases for infants under 1 month of age and for 1-3 months of age for those who look 
unwell(8).  
 7 
Even though there are a lot of different guidelines and criteria to use when assessing the risk 
that an infant has an SBI, the adherence has been low (3). The fact that medical personnel 
neither perform all recommended testing, nor give antibiotics or admit the infant when 
recommended has lately resulted in the guidelines being questioned because of the good 
outcomes for these children (9-11). The recommendations from the different criteria and 
guidelines could also lead to unnecessary and increased risks by invasive procedures, higher 
costs for medication and inpatient care as well as pain and added stress for the infant and its 
parents (12).  
In Gothenburg this has not been studied or evaluated. Hence, analysis of management and 
outcome of febrile young infants in Gothenburg, Sweden is of great value not only for quality 
assurance but also to serve as base line data for possible future intervention studies 
Evolution of clinical management  
Previously, it was up to the caring physician of a febrile infant to decide which test and 
procedures to perform and whether the patient needs hospitalization and antibiotics. The 
recommendation at that time was often to perform a full work up in all febrile infants 
independent of laboratory tests and clinical picture. But in the 1990’s several studies were made 
and new protocols were introduced for the management of febrile infants under 90 days of age 
with a fever without source (FWS): The Rochester- (6), Boston- (13) and Philadelphia criteria 
(14) were the most common and will be referred to as “the classic criteria” in this report. All 
three criteria recommend blood and urine test for risk evaluation of febrile children to be able 
to assign them as “low-risk patients”. This means that they are at low risk for having an SBI 
with no need of further testing, antibiotic treatment or hospitalization and can leave the PED 
with advice about what their caregivers should be aware of (4, 6, 13, 14). 
 8 
The criteria that need to be met in order to be classified as a “low risk patient” according to the 
different criteria are based on appearance at the PED visit, medical history, clinical examination 
and laboratory testing (table 1). The main differences between the different classic criteria are 
the need for invasive procedures such as LP and the differences in age. Rochester is the only 
one that includes infants under the age of 28 days (4) while the majority of the other guidelines 
recommends a full sepsis work up for these children. 
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Low-risk markers: Rochester-, Boston- and Philadelphia criteria 
Criteria Rochester  Boston Philadelphia 
Age (d)  60  28 – 89 29 - 56 
Temperature 
(C) 
 38.0 (rectal T*)  38.0 (rectal T*)  38.2 (rectal T*) 
Medical 
history  
• 37 weeks gestation at 
birth 
• No perinatal antibiotics 
• No treatment for 
unexplained 
hyperbilirubinemia 
• Not received nor 
receiving antimicrobial 
agents 
• No previous 
hospitalization  
• No underlying or 
chronic illness 
• Not hospitalized longer 
than mother at birth 
• No antimicrobial agents 
within 48 hours 
• No immunization 
within 48 hours 
• No allergies to -lactam 
antimicrobial agents 
Not defined 
Physical 
examination at 
ED 
• Well appearing  
• No sign of skin, soft 
tissue, bone or ear 
infection 
• Well appearing  
• No sign of skin, soft 
tissue, bone or ear 
infection 
• Well appearing  
• Unremarkable 
examination 
Laboratory 
values 
• Peripheral blood WBC* 
5 – 15 x 109cells/L 
• Absolute Band count 
1.5 x 109cells/L 
• Urine WBC 10/hpf* 
• If diarrhea; stool smear 
5 WBC*/hpf* 
• Peripheral blood WBC* 
<20 x 109cells/L 
• UA* < 10 WBC*/hpf* 
• CSF* < 10  x 106 cells/L 
• Chest x-ray: no infiltrate 
(if obtained) 
• Peripheral blood WBC* 
<15 x 109cells/L 
• UA* < 10 WBC*/hpf* 
• CSF* < 8 x 106 cells/L 
• Band-neutrophil ratio < 
0.2 
• CSF*: Gram stain 
negative 
• Urine: Gram stain 
negative 
• Stool: no blood, few or no 
WBCs on smear (if 
indicated) 
• Chest x-ray: no infiltrate 
Management 
for low risk 
patients 
Home or outpatient care 
No antibiotics 
Follow-up required 
Home or outpatient care 
Empiric antibiotics 
Follow-up required 
Home or outpatient care 
No antibiotics 
Follow-up required 
* T =Temperature; WBC = white blood count; hpf = high power field; UA= urinalysis; CSF = cerebrospinal fluid 
Table 1 Definition of low-risk markers for SBI in classic clinical prediction models. Adapted and inspired by Hui et al 
(4) 
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After Rochester, Boston and Philadelphia criteria there have been a lot of studies on the 
management of the febrile infant with few new inputs on the management protocol. One of the 
more validated is the “Step-by-step” approach (15, 16). Newer studies have also evaluated the 
accuracy of new diagnostic tests like Procalcitonin (PCT) or C-reactive protein (CRP) that can 
be combined with parts of the classic protocols to help identify SBI in febrile infants and avoid 
excessive antibiotic treatment, hospitalization or invasive procedures like LP (9).  
The “Step-by-step”-approach (15, 16) is one of the newer protocols that has been introduced in 
several PEDs. The purpose is to identify the infants at risk for IBI and select those who safely 
can be sent home from the PED without AB or LP 
(16).  
It is, like the classic criteria, based on appearance at 
PED and age but also takes into account the 
following laboratory parameters; urinalysis (UA), 
CRP, PCT and absolute neutrophil count (ANC). 
Limits for age and laboratory values are shown in 
the flowchart displayed in figure 1. 
The negative predictive value(NPV) and the 
sensitivity of the  Step-by-step approach, Rochester-
, Boston- as well as the Philadelphia criteria to 
identify SBIs have been shown to be quite high 
(NPV 89.7-100.0%, sensitivity 93.7-100.0%) but 
specificity and positive predictive value are generally 
in the lower range (4, 9, 14, 15). This means that 
Figure 1 - The Step-by-step approach. 
Image inspired from Mintegi et al (16) 
PCT=procalcitonin; CRP= c-reactive protein; 
ANC=absolute neutrophil count 
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majority of the ill infants are in fact detected as ill upon testing as well as the healthy infants 
are detected as low risk infants by the different guidelines. 
Role of diagnostic markers in ruling out SBI in febrile infants 
CRP, PCT and Interleukin-6 (IL-6) are newer laboratory markers that have made their way into 
the evaluation of the risk of SBI in febrile infants, more specifically predicting if the infant has 
an SBI rather than identifying them as a low-risk patient (9). Neither of them are recommended 
as a single test for predicting SBI and an exact cut-off limit has not been determined for 
predicting the risk of an SBI in any of them. However, when they are combined with other 
markers and test like in the “Step-by-step” approach they might help to identify febrile infants 
with SBI (17-21).  
CRP is an acute phase reactant that can be found in serum in a majority of bacterial-, viral- and 
other inflammatory illnesses (22). It is synthesized in the liver after 4-6h as a response to tissue 
injury or inflammation somewhere in the body and has its peak somewhere within 36-50h after 
first stimulus (23). 
PCT is a precursor of calcitonin and it can be found in high levels in patents with bacterial 
infections. It has its peak at 12h and starts to rise already after 6-8h after the first sign of 
infection. This makes it easier to detect in higher concentrations earlier than CRP which has its 
peak several hours later (24, 25).   
IL-6 is one of the markers that also might help with early detection of infectious disease in 
febrile infants (20). Being one of the proinflammatory cytokines that contributes to the 
production of CRP from the liver. It can also be detected in high levels in serum before CRP 
with a mean peak time of around 12h (19, 26). 
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Aim 
The aim of this study is to describe the management and outcome of febrile infants visiting the 
pediatric emergency department in Gothenburg and further to compare it with international 
guidelines for febrile infants under 2 months of age.  
Material and Methods  
Study design and study population 
This is a retrospective observational study which was 
performed at the Sahlgrenska Academy, University of 
Gothenburg with medical records collected from patients at 
the PED at The Queen Silvia Children´s Hospital in 
Gothenburg between 1st of January 2015 to 31st of December 
2017. The total number of visits for infants 60 days during 
these years were 6381 and out of these there were 825 who 
had a fever as the main complaint when visiting the PED. 
All included patients were 60 days of age and with a 
documented temperature of 38C or above measured either at 
home (guardian report) or/and at the PED. 
Exclusion criteria were: gestational age <35 weeks; severe 
congenital or acquired medical condition; hospital admission 
or antibiotic treatment in the proceeding ten days; temperature 
below 38.0C; incomplete medical records (no registered or 
measured temperature); no encounter with a medical doctor 
Infants with a fever as main 
reason for visit and 60 days of 
age, n=825
Gestational age <35 weeks 
were excluded, n=14
severe congenital or 
aquired condition were 
excluded, n=7
admitted or had 
antibiotics in last 10 days 
were excluded, n=15
no measured temp above 
38 were or incomplete 
records excluded, n=88
Didn't see doctor or 
deviated were excluded, 
n=38
Revisits were excluded, 
n=38
Patients included in the study 
after exclusions, n=625
Figure 2 – Flow chart of the inclusion and 
exclusion process of patients in this study 
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before leaving the PED. Revisits were also excluded and registered as a follow up of the initial 
visit to the PED if visit took place in the previous 10 days. 
 
 
 
Data collection  
The patients in this study were all collected through a program called Cognos analytics. It uses 
the information from ELVIS (a patient registration program used by Sahlgrenska Hospitals) to 
collect and sort out a group of patient visits to the PED that match the study inclusion criteria; 
i.e. patient age 60 days of age and with a fever as the main complaint during 1st of January 
2015 to 31st of December 2017. The patient visits matching these screening criteria were listed 
with social security number, date of visit and also date of discharge from ward if admitted.  
Study definitions  
Fever Measured body temperature  38C at home or at the PED 
Fever without 
source (FWS) 
Temperature  38.0C measured at home or at the PED in well appearing 
patients with a normal physical examination without signs or symptoms 
from respiratory tract or skin. 
Well appearing Defined as physician not describing infants’ condition as “not well” or 
“irritable” in analyzed medical records. 
SBI: Serous bacterial infection such as bacteremia, pyelonephritis or 
meningitis, also in combinations with each other. 
Bacteremia Isolated bacteria in blood culture (coagulase-negative staphylococci 
(CoNS) was considered contamination if not stated otherwise)   
Pyelonephritis Significant growth in a urine culture  
(E. Coli requires growth of 10,000 colony forming unit (CFU)/ml and a 
CRP 20 for diagnosis). 
Meningitis Elevated white blood cell count (WBC) in CSF or positive CSF culture. 
Delayed SBI 
diagnosis 
If SBI diagnosis was made after the initial approach i.e. at ward, at revisit 
or if the patient were sent home before diagnosis and treatment. This 
meant that the physician did not consider SBI as a possible diagnosis at 
first approach. 
Final study 
diagnosis 
Final diagnosis when discharged from the hospital as interpreted by 
author in analyzed medical records, mainly referring to FWS diagnoses. 
SBI assigned as written in medical journals if equivalent to the study 
definitions above. 
Table 2 Definitions of terms and their meaning used during the collection of medical records of participants in 
this study 
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The patient visits collected through our Cognos screening were all analyzed based on our 
inclusion and exclusion criteria listed above. All were anonymized and replaced with a study 
ID when the final group of included patient visits were completed. 
The retrospective information collected systematically after inclusion was age, gender, vital 
signs and RETTS (rapid emergency triage and treatment system) assessment. Additionally, 
symptoms described by guardian, findings from physician’s examination, laboratory values and 
initial- as well as final diagnosis and treatment were collected from medical records and 
registered in REDCap. 
Statistical methods 
To calculate and analyze results in this report SPSS version 25 (IBM Corp., Armonk, New 
York) was used. To calculate the significance for each variable Mann-Whitney U for non-
parametric variables and Chi-square test were used for variations in laboratory testing, 
treatment, outcome and revisits. For other results like Gender, age or SBI descriptive and 
frequency statistics were used. 
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Ethics 
The study was conducted according to the Helsinki Declaration and approved by the central 
ethical review board in Lund, Sweden (Dnr 2017/967 and 2018/831), since it is part of a larger 
national study. Because the study is retrospective the management and the information has 
already been collected and the author have no part in or need for information about future 
treatment of the patients. Each patient visit received a study ID upon inclusion which means 
the identity of the infant will not be registered by their social security number and will therefore 
be anonymous and unable to trace. This means that the main ethical problem that can be faced 
and need to consider is data mismanagement. 
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Results 
Study group characteristics 
Out of the 625 included infants 0-60 days of age, 44.3% (n=277) 
were female and 55.7% (n=348) were male. The median age of 
patients was 38 days and with a mean age of 37.4 days. Mean 
temperature at the PED was 38.3C and 86.7% of the patients had 
a fever duration <24h and 69.4% <12h as shown in table 3. 
The majority, 77.9% (n=487) had a gestational age of 37-42 weeks, 3.7% (n=23) were born at 
35-36 weeks and 3.5% (n=22) were born at >42 weeks. Also, 14.9% (n=93) were categorized 
as presumably term because lack of information in collected medical records and nothing else 
stated that the infant was premature. 
Exclusive breastfeeding was the most common with 57.3% (n=358) of 625 infants, 23.4% 
(n=146) were partially breast fed, 11.4% (n=71) only using formula and lastly 8% (n=50) 
unknown. 
 
 
 
 
 
 N (%) 
<6 h 245 (39.2) 
6-12 h 189 (30.2) 
12-24 h 108 (17.3) 
24-48 h 31 (5.0) 
>48 h 18 (2.9) 
Unknown 34 (5.4) 
Total 625(100.0) 
Table 3 Fever duration before first 
examination in total study 
population, as described by parents. 
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Final study diagnosis 
The three most common final 
study diagnoses were FWS, 
upper respiratory tract infection 
(URTI) and SBI. A total of 
47.5% (n=297) of the study 
population were diagnosed as 
having a FWS, followed by 
26.9% (n=168) having a URTI 
and 10.6% (n=66) diagnosed 
with SBIs, as shown in table 4. 
Pyelonephritis was the most 
common accounting for 78.8% 
of the SBIs, and the most 
frequent pathogen was 
Escherichia coli. 
The last group of patients mentioned as “other” referring to patients with conditions like 
varicella zoster, viral encephalitis, fever triggered by vaccinations, hand, foot and mouth 
disease or roseola infantum. Additionally, patients being transferred to other hospitals without 
proper final diagnosis in reviewed medical journals were also identified as other diagnosis. 
17.6% (n=110) infants out of 625 were initially treated as an SBI with empirical antibiotics, but 
only 51.8% (57/110) out of these had an SBI as final study diagnosis at discharge from the 
hospital. 30/62 in the younger age group (0-30 days) and 27/48 in the older age group (31-60 
days). 
 N (%) % of SBI 
SBI: *  66 (10.6) 100.0 
Pyelonephritis 52 (8.3) 78.8 
Meningitis 2 (0.3) 3.0 
Bacteremia 6 (1.0) 9.1 
Pyelonephritis + 
Bacteremia 
4 (0.6) 6.1 
Meningitis + Bacteremia 1 (0.2) 1.5 
Pyelonephritis + 
Meningitis + Bacteremia 
1 (0.2) 1.5 
FWS* 297 (47.5)  
URTI* 168 (26.9)  
Otitis 49 (7.8)  
Bronchiolitis 14 (2.2)  
Viral meningitis 11 (1.8)  
Pneumonia 5 (0.8)  
Influenza 4 (0.6)  
Gastroenteritis 2 (0.3)  
Skin infection 1 (0.2)  
Other a 8 (1.3)  
Total  625 (100)  
Table 4 Final study diagnoses in total population and percentage of 
each diagnosis amongst SBI group. 
* SBI= Serious bacterial infection; FWS= fever without source; 
URTI = Upper respiratory tract infection 
a= viral infections, fever triggered by vaccination and transferred 
patients 
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Nine out of the 66 patients who received an SBI diagnosis as final study diagnosis were not 
considered as having an SBI at initial approach. On the other hand, 64 out of 66 SBI patients 
received AB at initial approach. 64 had no clinical focus and 2 had upper respiratory tract focus 
at physical examination at first visit.   
Four out of 66 (6.1%) received their diagnosis and the appropriate treatment after initial 
approach. Two bacteremia, both got empirical antibiotics from the ED but were sent home 
without AB the morning after because they were well-appearing. They were both later admitted 
and treated with AB because of positive blood cultures (GBS and GAS). Also, there were one 
meningitis where AB first was initiated after admission. Lastly, one pyelonephritis who had 
visited the ED the day before admission but was sent home without treatment. All four were 
well at discharge from the hospital.  
There were two deaths (0.3%), of whom one patient had a sepsis and meningitis and one a 
pneumonia. One of them was later found to be born with asplenia. The patient who had sepsis 
and meningitis was given meropenem upon initial approach. The patient with pneumonia 
received antibiotic treatment upon revisit to the PED. 
SBI vs Non-SBI patients  
There was a significant difference in mean as well as median temperature (p-value <0.001) and 
pulse at first examination (p-value <0.008), first CRP (p-value <0.001), first IL-6 (p-value 
<0.001), as well as WBC (p-value <0.001) (table 4). 
Also, leukocyturia was present in 54/65 (83%) of patients with an SBI and in 71/457 (16%) that 
did not have an SBI (p=0.001). 
The non-SBI patients with leukocyturia (n=71) were diagnosed and distributed as 43 patients 
with FWS, 16 URTI, 1 gastroenteritis, 1 skin infection, 9 otitis as well as 1 roseola infantum. 
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 SBI group, 
mean/median (n) 
Non-SBI group,  
mean/median (n) 
P-value a 
Mean/median 
temperature at PED (C) 
38.8 / 38.9 (66) 38.2 / 38.2 (557) < .001 
Mean/median CRP  51.3 / 45.5 (66) 7.2 / 0.0 (476)  < .001 
Mean/median IL-6  684.3 / 98.5 (46) 276.7 / 31.9 (365) < .001 
Mean/median WBC  13.8 / 14.0 (52) 9.1 / 8.3 (377) < .001 
Mean/median pulse  170.2 / 171.0 (60) 163.5 / 163.0 (537) 0.008 
Mean/median 
respiratory rate 
54.8 / 55.5 (30) 52.6 / 52.0 (295) 0.468 
Mean/median saturation 97.6 / 98.0 (61) 97.9 / 98.0 (539) 0.212 
 
Variations in management  
Variations in management of febrile young infants 0-60 days of age divided into age-groups 
are listed in table 6. The majority in both age groups had only urine analysis (urine dipstick by 
clean catch or suprapubic puncture) performed with 49.3% in the 30 days group and 68.8% in 
the 31-60 days group. The difference in proportions in admission between the two age groups 
were almost inverted with 66.5% in the 30 days group being admitted while it was only 38% 
in the 31-60 days group.  
29.4% (184/625) of the infants were treated with AB at first approach and 33.4% (209/625) got 
AB sometime during their stay at the hospital regardless if they were sent home or admitted. 
44.7% (96/215) of the younger infants got AB at first approach. 
The most prescribed or used antibiotics amongst the 625 patient visits was cefotaxime at 7.2%, 
penicillin V at 6.2%, followed by Ceftibuten at 5.9% and Meropenem at 4.2%. Antibiotics used 
Table 5 Difference in mean temperature, CRP, IL-6, WBC, pulse, respiratory rate and saturation between 
the SBI and non-SBI group at first examination at PED. 
 
a= P value determined by Mann-Whitney U test 
CRP=c-reactive protein; IL-6=interleukin-6; WBC= white blood cell count; PED=pediatric 
emergency department 
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in hospitalized patients are shown in table 5. Most prescribed antibiotics in the group sent home 
from PED (n=33) were penicillin V (n=30) followed by ceftibuten (n=2) and erythromycin 
(n=1) 
In the total population, 13.8% (86/625) had a lumbar puncture taken, 28.4% in the younger age 
group. 24.3% (152/625) had a blood culture done, 83.5% (522/625) had a urine dipstick and 
24.2% (151/625) of the patients had a urine culture done. 
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Total 
(n=625), n 
(%) 
 
30 days 
(n=215), n 
(%) 
 
31-60 days 
(n=410), n 
(%) 
 
P-value h 
Laboratory testing a,d  
Urine + Blood + CSF  69(11.0) 50(23.3) 19(4.6) <.001 
Urine + Blood   62(9.9) 30(14.0) 32(7.8) 0.015 
Urine Only  388(62.1) 106(49.3) 282(68.8) <.001 
Other combinations of 
urine, blood, CSF 
24(3.8) 14(6.5) 10(2.4) 0.012 
None  82(13.1) 15(7.0) 67(16.3) 0.001 
Treatment a  
AB at first approach 183(29.3) 95(44.2) 88(21.5) 0.018 
Hospitalized: f  
AB at first approach  150(50.2) 86(60.1) 64(41.0) <.001 
AB at ward 25(8.4) 14(9.8) 11(7.1) 0.20 
No AB 124(41.5) 43(30.1) 81(51.9) 0.947 
Type of antibiotic: i  
Cefotaxime 52(29.7) 27(27.0) 25(33.3)  
Ceftibuten 37(21.1) 12(12.0) 25(33.3)  
Meropenem 27(15.4) 22(22.0) 5(6.7)  
Cefotaxime + 
Gentamycin 
13(7.4) 10(10.0) 3(4.0)  
Cefotaxime + Ampicillin 13(7.4) 11(11.0) 2(2.7)  
Other PO or IV 
combinations 
33(18.9) 18(18.0) 15(20.0)  
Discharged from PED: e  
AB at first approach 33(10.1) 9(12.5) 24(9.4) 0.529 
No AB 293(89.9) 63(87.5) 230(90.6) <.001 
Acyclovir g 12(1.9) 9(4.2) 3(0.7) 0.003 
Outcome b  
Hospitalized 299(47.8) 143(66.5) 156(38.0) <.001 
Home 326(52.2) 72(33.5) 254(62.0) <.001 
Revisits c  
10-d revisit e 56(17.2) 13(18.1) 43(16.9) 0.353 
10-d revisit resulting in 
hospitalization e 
19(5.8) 5(6.9) 14(5.5) 0.427 
Table 6 Patient-level variation in management and outcome of patients  60 days with fever at The 
Queen Silvia Children´s Hospital. 
a= testing or treatment performed at PED, ward or revisit 
b= outcome of first initial PED-visit 
c= revisits within 10 days, planned or not planned. 
d=urine testing defined as urine dipstick, urine culture or UriCult; blood testing as blood culture; 
CSF as cell count, culture or lumbar puncture. 
e=Percentage among discharged patients after first PED-visit. 
f= Percentage among hospitalized patients after first PED-visit. 
g= Percentage among total study population 
h= P-value determined by Chi-square test 
i= Percentage among hospitalized patient that received antibiotic treatment. 
PED=pediatric emergency department; AB=antibiotics 
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Discussion and conclusion 
This study included 625 febrile newborns under the age of 60 days visiting the pediatric 
emergency department in Gothenburg. The study presented a low frequency (13.8%) of LP as 
well as a low frequency (29.4%) of AB treatment in the overall group. Moreover, the frequency 
of LP among the younger infants (0-30 days) were 28.4% and barely 60.1% of the hospitalized 
0-30-day patients got treated with AB. Despite the low frequency of LP in this study there were 
no missed cases of meningitis, which may imply that excessive testing like LP for all 0-30-day 
febrile infants might be unnecessary when well-appearing and without other clinical signs.  
The most frequent final study diagnosis was fever without source with 47.4%, followed by 
upper respiratory tract infections at 26.9%. In other words, the majority of the patients visiting 
the PED with fever as main complaint had no SBI. SBI were only diagnosed in 10.6% of the 
population. These 10.6% were distributed as 8.3% pyelonephritis, 1.0% bacteremia and 0.3% 
meningitis and 1% consisting of different combinations of the three. The percentage of SBIs in 
this study were in the lower range compared to other big studies with similar inclusion criteria 
who had SBI frequencies between 8.4 - 22.4%. The main difference seen in frequency of 
pyelonephritis patients and the different definitions of SBI can be because this study included 
all febrile infants from the PED not just the ones diagnosed as FWS (10, 14, 16, 27-29).   
Pyelonephritis represented the majority of SBI diagnoses in all analyzed age groups. The higher 
percentage in this study compared to other studies (10) can be explained by the definition for 
urinary tract infection or pyelonephritis. Our study included infants with a CFU above 10,000 
and a CRP 20 when Escherichia coli was found in positive urine cultures whereas other studies 
have a limit of >100,000 CFU or 50,000 CFU together with an abnormal urine analysis (30). 
The different limits regarding culture results therefore might be a reason for the difference in 
results but the main reason might also be the limit for CRP in this study. 
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Nonetheless, pyelonephritis represented the vast majority of the SBI diagnoses, 83% of the SBI 
patients had leukocyturia compared to 16% amongst the non-SBI patients. This should imply 
the importance of urine analysis, i.e. a negative result reduces the risk of the infant having an 
SBI. Importantly, it also helps the treating physician make a correct diagnosis with a simple 
and sometimes non-invasive test, since most of our urine analyses are performed by clean catch 
urine samples. The recommendation for some type of urine test is also concluded and 
recommended by Jaskiewicz et al(6), Baker et al(14) as well as the NICE-guideline (8). 
Furthermore, the overall hospitalization rate for this study was 47.8%. Though, it was 66.5% in 
the younger age group and 38.0% in the older age group. The more frequent hospitalization of 
infants up to 30 days of age may stem from the majority of the international guidelines, except 
the Step-by-step approach, recommending hospitalization for all infants in this age group as 
well as AB treatment or that the perceived risk of SBI is higher than in the 31-60-day group. 
This probably also explains the difference in antibiotic treatment amongst the hospitalized 
patients (29). 
Variation in laboratory testing also shows that physicians are more prone to do a full work up 
with urine-, blood- and CSF cultures on the younger population. Still the frequency of 
hospitalization and AB treatment among 0-30 day of age hospitalized infants is lower in this 
study than in other international studies with a frequency between 79.4-96.1% in AB treatment 
and a 78.3-83.6% hospitalization rate (3, 10, 29).  
Overall, the study shows that infants with SBI are found and treated at the PED in Gothenburg 
regardless the lack of a set guideline to follow for febrile infants under 60 days of age. The 
majority of the patients had their vitals taken: temperature, pulse and saturation. As well as 
WBC, CRP and IL-6 analyzed at first approach. In comparison to the classical criteria 
introduced earlier in this report the results show that when it comes to medical evaluation the 
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only criteria that are in some way followed are the Rochester criteria because the lack of 
invasive procedures while Boston- and Philadelphia criteria recommend LP.  
The “Step-by-step” approach recommends urine test, PCT, CRP or ANC which are done for a 
high number of patients at the PED in Gothenburg except for the PCT test which was done in 
1 out of the 625 patients. PCT (24, 25) and IL-6 (19) has similar peak time and are both 
recommended as tests for predicating infectious disease making them comparable and in this 
study IL-6 seems to be the test of choice.  
Consequently, making it clear that when PCT are replaced by IL-6 testing the “step-by-step” 
approach are the guideline closest to the type of evaluation used at the PED in Gothenburg for 
febrile children under 60 days of age with fever as main complaint. If IL-6- or CRP levels are 
high physicians may continue with SBI evaluation as cultures and other testing as well as 
antibiotic treatment. While if IL-6- or CRP levels are low in otherwise well-appearing infants 
they are usually discharge from the PED with parental advice and a low threshold for revisits.   
Strengths and limitations 
Retrospective studies such as this one has a couple of disadvantages, one being that it is 
impossible to control the assessment and outcome that was done for each patient. Only trusting 
notes from medical records, which can vary in quality and can easily be misinterpreted. Also, 
the fact that the same patient could be evaluated differently by two different medical doctors. 
Another disadvantage is that the reviewing of medical records can be colored by the reviewer 
and when this is done by several people, in this case two different persons, some factors can be 
interpreted in different ways.  
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Thirdly, our inclusions criteria of only including patients with fever being their main complaint 
when visiting the PED makes it possible for SBI patients being missed because they were 
registered under other complaints in ELVIS when visiting the PED. 
Strengths of this study are that all included patients visited the same PED which makes it easier 
to assume that the evaluation of each patient were more consistent than if it were several 
different PEDs, which also was seen in the results showing significant difference in treatment 
between the different age groups but similar management amongst them.  
Secondly, the number of included patients is a strength because we could see trends and 
differences amongst the whole population as well as between the age groups. 
More strengths are that this is, to our knowledge, one of the first studies of its kind in Sweden 
and Gothenburg showing significant trends of management. It can be used when composing the 
necessary prospective studies needed in this field in the future, hopefully resulting in new 
guidelines for febrile infants under 60 days of age. 
Conclusion 
Outcome for febrile infants at the PED in Gothenburg is favorable although more restricted 
management with low frequency of lumbar punctures, antibiotic treatment and admission rate 
amongst the youngest infants as well as in the overall group was observed compared to other 
international studies. 
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Populärvetenskaplig sammanfattning  
Feber hos barn under 2 månaders ålder: klinisk handläggning och utfall 
Feber är en utav de vanligaste anledningarna till att småbarn besöker akutmottagningen. 
Rekommendationer från BVC och annan vårdpersonal ser ut på detta sätt då spädbarn har en 
hög risk för svåra bakteriella infektioner, ett begrepp som innefattar potentiellt livshotande 
tillstånd. Detta innefattar bland annat sjukdomar där dåliga bakterier till exempel har tagit sig 
till hinnorna som omger hjärnan, till njurarna eller att de går att hitta i blodet och därmed gör 
oss sjuka. 
Läkare har idag en stor utmaning i att urskilja dessa sjuka barn och bestämma vilka som är 
säkra att skicka hem utan fler undersökningar och vilka som bör genomgå fler tester. 
Svårigheten i att ta emot dessa barn ligger i att barnen inte alltid visar upp typiska tecken eller 
visar väldigt vaga sådana trots allvarlig sjukdom. 
För att underlätta denna utmaning finns det diverse riktlinjer som läkarna kan följa. Vissa 
rekommenderar ryggvätskeprov och antibiotikabehandling medan andra riktlinjer ser att barn 
som ej uppvisar avvikelser på blodprover eller fysisk undersökning bör skickas hem utan 
antibiotika men med uppföljning samt råd till föräldrarna.  
Även fast det finns olika riktlinjer som ska underlätta för läkarna så följs dem inte i de flesta 
fall. Trotts det har det inte varit något större antal ”missade” barn med dessa allvarliga tillstånd 
vilket har lett till att riktlinjerna har börjat ifrågasättas.  
Vårt syfte med denna studie var därför att undersöka handläggningen och diagnoserna hos 
spädbarn med feber under två månaders ålder vid Göteborgs barnakut. 
Studien bestod av 625 spädbarn med sökorsak feber som besökt barnakuten mellan 1 januari 
2015 och 31 december 2017. Faktorer som undersöktes var bland annat: ålder, temperatur, 
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prover, inläggningsfrekvens, antibiotikabehandling, diagnos och om det skedde något återbesök 
samt resultatet av detta. Analyser genomfördes både genom att jämföra handläggning mellan 
barn i 0-30- samt 31-60 dagars ålder samt de med slutdiagnos svår bakteriell infektion mot de 
med andra diagnoser. 
Av de 625 inkluderade barnen så lades 48% in på avdelning och 29% fick antibiotika efter 
första besöket på akuten. 14% av hela gruppen genomgick ett ryggvätskeprov, motsvarande 
siffra i den yngre gruppen var 28%. 11% hade en svår bakteriell infektion, vanligast var 
infektion i njurarna som stod för 79% av dessa. Vi såg också betydande skillnader i genomförda 
undersökningar mellan de yngre och de äldre barnen i både provtagning, inläggningar och 
antibiotikabehandling. 
Slutsatsen av denna studie är att läkarna vid barnakuten i Göteborg följer de internationella 
riktlinjerna med viss modifikation. Också att de handlägger spädbarn med feber på ett sådant 
sätt som ändå gör att de svåra infektionerna upptäcks och att barnen får rätt behandling. En 
annan sak var även att det genomförs betydligt färre ryggvätskeprov samt att Göteborgs 
barnakut har en lägre frekvens av antibiotikabehandling jämfört med annan internationell 
barnakutsjukvård. 
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